K-numberK252392
Device nameMillipede70 Aspiration Catheter; Perfuze Aspiration Tube Set
ApplicantPerfuze, Ltd.
Product codeNRY
Device classClass II
Decision dateAug 29, 2025
DecisionSubstantially Equivalent
Regulation870.1250
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Millipede70 Aspiration Catheter with Perfuze Aspiration Tube Set is a neurovascular device designed to remove blood clots from the brain in acute ischemic stroke patients. It uses direct aspiration to revascularize patients with large vessel blockages in the intracranial arteries within 8 hours of symptom onset and is intended for patients who cannot receive or have failed thrombolytic drug therapy.

Technological characteristics

The subject device is a single-lumen, reinforced catheter with variable stiffness, hydrophilic coating, and a radiopaque distal marker. The only design change from the predicate is a minimal increase in maximum outer diameter at the distal end from 0.0835 inches to 0.0837 inches. All materials, sterilization method (ethylene oxide), working length (136 cm), and the Perfuze Aspiration Tube Set design remain identical to the predicate device.

Test standards cited

Not stated in this summary. The document references bench testing methods (dimensional verification, simulated use, visual inspection, hydrophilic coating integrity, kink resistance, tip stiffness, and torque strength) but does not cite specific consensus standards such as ISO, IEC, or ASTM numbers.

Substantial equivalence argument

Substantial equivalence is supported because the subject and predicate devices share identical indications for use, fundamental design, operating principle, materials, and sterilization. The 0.0002-inch increase in distal outer diameter does not raise different safety or effectiveness questions; successful completion of bench testing (dimensional verification, simulated use, coating integrity, kink resistance, tip stiffness, and torque strength) demonstrates the subject device meets specifications and performs as intended under simulated conditions equivalent to the predicate.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →